Wednesday, February 12, 2025 7:27:53 PM
this could spell trouble for shorts.
stock is showing great strength.
news today is massive and has widespread implications.
licensing options
buyout possibility
partnerships
now this company has so many options.
stock is showing great strength.
news today is massive and has widespread implications.
licensing options
buyout possibility
partnerships
now this company has so many options.
Recent VBIO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 09:29:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/14/2026 08:36:14 PM
- Valion Bio's Velocity Bioworks Secures Exclusive Commercial License to LarmorBio's BioScan-NMR™ Platform • PR Newswire (US) • 05/14/2026 08:31:00 PM
- VALION BIO REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS • PR Newswire (US) • 05/14/2026 08:05:00 PM
- Valion Bio to Report First Quarter 2026 Financial Results on May 14, 2026 • PR Newswire (US) • 05/11/2026 12:01:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/08/2026 09:02:54 PM
- Valion Bio Celebrates Grand Opening of Velocity Bioworks Biomanufacturing Facility in San Antonio, Anchoring Domestic Production of Entolimod™ • PR Newswire (US) • 05/06/2026 12:08:00 PM
- VALION BIO RECEIVES FIRST FDA-PRECEDENT STUDY PROTOCOL FROM NIAID FOR ENTOLIMOD™; FEDERAL AGENCY TO FULLY FUND BLA-ENABLING IN VIVO PROGRAM AND CO-NAVIGATE FDA SUBMISSION • PR Newswire (US) • 05/05/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:08:18 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/04/2026 08:07:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/04/2026 08:05:18 PM
- Valion Bio Appoints Melinda Lackey as General Counsel • PR Newswire (US) • 05/04/2026 08:05:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 12:15:02 PM
- VALION BIO BRIEFS PENTAGON LEADERSHIP ON ENTOLIMOD™ FOR ACUTE RADIATION SYNDROME • PR Newswire (US) • 04/28/2026 12:01:00 PM
